Metachronous gastric MALT lymphoma and early gastric cancer: is residual lymphoma a risk factor for the development of gastric carcinoma?
Open Access
- 12 May 2005
- journal article
- case report
- Published by Elsevier in Annals of Oncology
- Vol. 16 (8) , 1232-1236
- https://doi.org/10.1093/annonc/mdi242
Abstract
Background: Helicobacter pylori plays a major role in the pathogenesis of primary gastric MALT lymphoma (GML) and gastric carcinoma. The occurrence of these two diseases metachronously in a same patient is a rare event. Patients and methods: Gastric biopsies and gastrectomy resection specimens of four patients who developed GML and early gastric cancer (EGC) were analysed by morphology, immunohistochemistry and molecular biology. Results: Four patients (three males and one female; mean age 48 years) were diagnosed with GML. Helicobacter pylori infection was observed in three cases. Two patients had localized disease (stages IE and IIE, respectively) and were treated with H. pylori eradication therapy followed by an alkylating agent for one patient. Two patients had disseminated disease (stage IV), and were treated with an alkylating agent. Three cases were t(11;18) positive. All patients achieved initially complete lymphoma remission. Long-term endoscopic surveillance detected an EGC at the same location as the lymphoma in all patients at a mean time of 9.5 years (range 2.5–17 years) after lymphoma diagnosis. Gastrectomy specimens showed residual GML in all cases. Conclusion: Prolonged residual GML could constitute an additional risk factor for the development of gastric carcinoma. Long-term endoscopic surveillance is mandatory in patients treated conservatively for gastric MALT lymphoma.Keywords
This publication has 20 references indexed in Scilit:
- Factors predicting progression of gastric intestinal metaplasia: results of a randomised trial on Helicobacter pylori eradicationGut, 2004
- T(11;18) is a marker for all stage gastric MALT lymphomas that will not respond to H. pylori eradicationGastroenterology, 2002
- Molecular follow-up in gastric mucosa-associated lymphoid tissue lymphomas: early analysis of the LY03 cooperative trialBlood, 2002
- Synchronous gastric adenocarcinoma and mucosa-associated lymphoid tissue lymphoma in association with Helicobacter pylori infection: comparing reported cases between the East and WestAmerican Journal of Gastroenterology, 2001
- Development of early gastric cancer 4 and 5 years after complete remission of Helicobacter pylori associated gastric low grade marginal zone B cell lymphoma of MALT typeWorld Journal of Gastroenterology, 2001
- Chemoprevention of Gastric Dysplasia: Randomized Trial of Antioxidant Supplements and Anti-Helicobacter pylori TherapyJNCI Journal of the National Cancer Institute, 2000
- Cyclooxygenase-2 Expression in Helicobacter pylori-Associated Premalignant and Malignant Gastric LesionsThe American Journal of Pathology, 2000
- Clone-specific PCR reveals wide dissemination of gastric MALT lymphoma to the gastric mucosaThe Journal of Pathology, 2000
- Synchronous adenocarcinoma and low grade B‐cell lymphoma of mucosa associated lymphoid tissue (MALT) of the stomachHistopathology, 1995
- Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pyloriThe Lancet, 1993